DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Fuchs C, Wauschkuhn S, Scheer C. et al.
Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days.
Br J Anaesth 2017;
119 (04) 616-625
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.